 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/24/2021 |
$118.68 |
$119.24 |
$118.08 |
$118.66 |
5.79M | | 11/26/2021 |
$117.61 |
$118.11 |
$115.83 |
$116.51 |
5.02M | | 11/29/2021 |
$116.83 |
$117.92 |
$116.58 |
$116.89 |
4.37M | | 11/30/2021 |
$116.68 |
$116.79 |
$115.10 |
$115.28 |
8.17M | | 12/01/2021 |
$115.78 |
$118.98 |
$115.61 |
$115.91 |
6.29M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on November 24, 2021, ABBV opened at $118.68, traded as high as $119.24 and as low as $118.08, and closed at $118.66. Trading volume was a total of 5.79M shares. On November 26, 2021, ABBV opened at $117.61, traded as high as $118.11 and as low as $115.83, and closed at $116.51. Trading volume was a total of 5.02M shares. On November 29, 2021, ABBV opened at $116.83, traded as high as $117.92 and as low as $116.58, and closed at $116.89. Trading volume was a total of 4.37M shares. On November 30, 2021, ABBV opened at $116.68, traded as high as $116.79 and as low as $115.10, and closed at $115.28. Trading volume was a total of 8.17M shares. On December 01, 2021, ABBV opened at $115.78, traded as high as $118.98 and as low as $115.61, and closed at $115.91. Trading volume was a total of 6.29M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/03/2013 |
|
| End date: |
12/01/2021 |
|
| Start price/share: |
$34.83 |
|
| End price/share: |
$115.91 |
|
| Starting shares: |
287.11 |
|
| Ending shares: |
416.31 |
|
| Dividends reinvested/share: |
$27.91 |
|
| Total return: |
382.55% |
|
| Average Annual Total Return: |
19.31% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$48,259.11 |
|
| Years: |
8.92 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/03/2013 |
|
| End date: |
12/01/2021 |
|
| Start price/share: |
$34.83 |
|
| End price/share: |
$115.91 |
|
| Dividends collected/share: |
$27.91 |
|
| Total return: |
312.92% |
|
| Average Annual Total Return: |
17.24% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$41,287.21 |
|
| Years: |
8.92 |
|
|
|
| Date |
Close |
| 11/24/2021 | $118.66 | | 11/26/2021 | $116.51 | | 11/29/2021 | $116.89 | | 11/30/2021 | $115.28 | | 12/01/2021 | $115.91 |
|
|
Free ABBV Email Alerts:
